| Name | Title | Contact Details |
|---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Americord Registry is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia.
Magellan Diagnostics is a North Billerica, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cano Health operates healthcare centers specializing in Senior Care and Primary Care for all ages. In addition to primary medical care, Cano Health has specialty programs in the fields of Venous Medicine, Arthritis, Allergy, and Weight Loss. OUR MISSION Our mission is to improve patient health by delivering superior primary care medical services, while forging a life-long bond with our members. OUR VISION Our vision is to become the national leader in primary care by improving the health, wellness, and quality of life of the communities we serve, while reducing health care costs.
MindClick Partners Inc is a West Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.